—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Bio-Rad Laboratories Inc (BIO) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for BIO, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 1 piece · newest: Midday 10, “A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000” (2026-08-21)

Mentioned on Closelooknet

Where BIO appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.66 to TLT · on the worst bond days it held up better than the market

How it trades on rate days

How BIO has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.66 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Bio-Rad Laboratories Inc moved 0.66% on average · correlation 0.17 · higher than 67% of US names
  • Beta, last 3 months 0.89 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.20% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days +2.29% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Medical Devices · United States · 8 names with week and year-to-date

Peer group

Medical Devices · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against BIO on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Bio-Rad Laboratories Inc

BIO in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Bio-Rad supplies tools for life-science research and for clinical diagnostics, organised into two segments. The Life Science side sells instruments, reagents and consumables that separate, purify and analyse cells, proteins and nucleic acids for laboratories, biopharma manufacturers and food-safety testers. The Clinical Diagnostics side sells test systems, test kits, informatics and quality controls used in hospital, reference and transfusion laboratories. It reaches customers directly and through distributors, and is based in Hercules, California.
Where it sits in the stack
Bio-Rad carries no seat in our Rubin index for the AI build-out, so it sits instead in the medical-devices sleeve of our wider universe, alongside other life-science tools and diagnostics suppliers.
Who it is priced against
The diary has not set a Closelooknet peer group for this name; the comparison the market usually draws is with Thermo Fisher Scientific, another supplier of life-science tools and diagnostics equipment of similar breadth.
Why Closelooknet tracks it
Bio-Rad holds a Russell 1000 seat but no Rubin seat and no Closelooknet score yet. It has appeared once in the diary, cited in a Midday 10 note that grouped it among health-care and biotech names making new highs alongside a broader ex-tech breadth thesis.
What the diary watches
Whether Bio-Rad keeps showing up on broad health-care new-high lists as a sign of sector-wide breadth, or whether its diagnostics and life-science segments start to diverge in trend.

Bio-Rad Laboratories Inc (BIO) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Bio-Rad Laboratories Inc (BIO)?

Bio-Rad Laboratories Inc trades as BIO on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is BIO in a Closelooknet index?

Not currently — Bio-Rad Laboratories Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does BIO trade against its moving averages?

Uptrend stack intact: Trades +6.1% vs the 50-day and +24.4% vs the 200-day average, 3.8% below the 52-week high and +60.9% off the 52-week low; a golden cross printed 43 sessions ago. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Bio-Rad Laboratories Inc trade when bond yields rise?

Over the past year Bio-Rad Laboratories Inc had a beta of 0.66 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 67% of US names. On the 10 sessions in which long bonds fell most it moved −0.20% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Bio-Rad Laboratories Inc?

Bio-Rad Laboratories Inc appears in 1 Closelooknet piece, most recently Midday 10: A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000 (2026-08-21). What Closelooknet said most recently: Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG… (Midday 10, 2026-08-21). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does Bio-Rad Laboratories Inc do?

Bio-Rad supplies tools for life-science research and for clinical diagnostics, organised into two segments. The Life Science side sells instruments, reagents and consumables that separate, purify and analyse cells, proteins and nucleic acids for laboratories, biopharma manufacturers and food-safety testers. The Clinical Diagnostics side sells test systems, test kits, informatics and quality controls used in hospital, reference and transfusion laboratories. The diary has not set a Closelooknet peer group for this name; the comparison the market usually draws is with Thermo Fisher Scientific, another supplier of life-science tools and diagnostics equipment of similar breadth.

Where does Bio-Rad Laboratories Inc sit in the AI build-out?

Bio-Rad carries no seat in our Rubin index for the AI build-out, so it sits instead in the medical-devices sleeve of our wider universe, alongside other life-science tools and diagnostics suppliers. Bio-Rad holds a Russell 1000 seat but no Rubin seat and no Closelooknet score yet. It has appeared once in the diary, cited in a Midday 10 note that grouped it among health-care and biotech names making new highs alongside a broader ex-tech breadth thesis.

What does this page show?

A live price chart with SMA overlays and drawing tools for BIO, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.